International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis

Katja Lakota, Gerhard G. Thallinger, Snezna Sodin-Semrl, Blaz Rozman, Ales Ambrozic, Matija Tomsic, Sonja Praprotnik, Sasa Cucnik, Katjusa Mrak-Poljsak, Angela Ceribelli, Ilaria Cavazzana, Franco Franceschini, Jiri Vencovsky, L. Czirják, Cecilia Varjú, Gunther Steiner, Martin Aringer, Bojana Stamenkovic, Oliver Distler, Marco Matucci-CerinicTanja Kveder

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Introduction: An international cohort study of 73 anti-Ku-positive patients with different connective tissue diseases was conducted to differentiate the anti-Ku-positive populations of patients based on their autoantibody profile and clinical signs/symptoms and to establish possible correlations between antibodies against Ku p70 and Ku p80 with autoimmune diseases.Methods: Sera of anti-Ku-positive patients were collected from six European centers and were all secondarily tested (in the reference center); 73 were confirmed as positive. Anti-Ku antibodies were detected with counter-immunoelectrophoresis (CIE), line immunoassay (LIA), and immunoblot analyses. All clinical and laboratory data were follow-up cumulative data, except for anti-Ku antibodies. Statistical analyses were performed by using R (V 2.12.1). The Fisher Exact test was used to evaluate the association between anti-Ku antibodies and diagnosis, gender, clinical signs, and other observed antibodies. The P values were adjusted for multiple testing. Separation of disease populations based on the presence of antibodies and clinical signs was investigated by principal-components analysis, which was performed by using thr// R's prcomp function with standard parameters.Results: A 16% higher prevalence of anti-Ku p70 was found over anti-Ku p80 antibodies. In 41 (57%) patients, a combination of both was detected. Five (7%) patients, who were CIE and/or LIA anti-Ku positive, were negative for both subsets, as detected with the immunoblot; 31% of the patients had undifferentiated connective tissue disease (UCTD); 29% had systemic sclerosis (SSc); 18% had systemic lupus erythematosus (SLE); 11% had rheumatoid arthritis; 7% had polymyositis; and 3% had Sjögren syndrome.Conclusions: A significant positive association was found between female patients with anti-Ku p70 and joint/bone features, and a significant negative association was found between female patients with anti-Ku p80 only and joint/bone features (P = 0.05, respectively). By using the first and the third components of the principal-component analysis (PCA) with 29 parameters evaluated, we observed that the anti-Ku-positive population of UCTD patients had overlapping parameters, especially with SLE, as opposed to SSc, which could be helpful in delineating UCTD patients.

Original languageEnglish
Article numberR2
JournalArthritis Research and Therapy
Volume14
Issue number1
DOIs
Publication statusPublished - Jan 6 2012

Fingerprint

Principal Component Analysis
Anti-Idiotypic Antibodies
Cohort Studies
Joints
Bone and Bones
Connective Tissue Diseases
Population
Immunoelectrophoresis
Antibodies
Systemic Scleroderma
Immunoassay
Systemic Lupus Erythematosus
Polymyositis
Autoantibodies
Autoimmune Diseases
Signs and Symptoms
Rheumatoid Arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

International cohort study of 73 anti-Ku-positive patients : Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis. / Lakota, Katja; Thallinger, Gerhard G.; Sodin-Semrl, Snezna; Rozman, Blaz; Ambrozic, Ales; Tomsic, Matija; Praprotnik, Sonja; Cucnik, Sasa; Mrak-Poljsak, Katjusa; Ceribelli, Angela; Cavazzana, Ilaria; Franceschini, Franco; Vencovsky, Jiri; Czirják, L.; Varjú, Cecilia; Steiner, Gunther; Aringer, Martin; Stamenkovic, Bojana; Distler, Oliver; Matucci-Cerinic, Marco; Kveder, Tanja.

In: Arthritis Research and Therapy, Vol. 14, No. 1, R2, 06.01.2012.

Research output: Contribution to journalArticle

Lakota, K, Thallinger, GG, Sodin-Semrl, S, Rozman, B, Ambrozic, A, Tomsic, M, Praprotnik, S, Cucnik, S, Mrak-Poljsak, K, Ceribelli, A, Cavazzana, I, Franceschini, F, Vencovsky, J, Czirják, L, Varjú, C, Steiner, G, Aringer, M, Stamenkovic, B, Distler, O, Matucci-Cerinic, M & Kveder, T 2012, 'International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis', Arthritis Research and Therapy, vol. 14, no. 1, R2. https://doi.org/10.1186/ar3550
Lakota, Katja ; Thallinger, Gerhard G. ; Sodin-Semrl, Snezna ; Rozman, Blaz ; Ambrozic, Ales ; Tomsic, Matija ; Praprotnik, Sonja ; Cucnik, Sasa ; Mrak-Poljsak, Katjusa ; Ceribelli, Angela ; Cavazzana, Ilaria ; Franceschini, Franco ; Vencovsky, Jiri ; Czirják, L. ; Varjú, Cecilia ; Steiner, Gunther ; Aringer, Martin ; Stamenkovic, Bojana ; Distler, Oliver ; Matucci-Cerinic, Marco ; Kveder, Tanja. / International cohort study of 73 anti-Ku-positive patients : Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis. In: Arthritis Research and Therapy. 2012 ; Vol. 14, No. 1.
@article{e3ef06c3fc81422eaf2ecf27622a97be,
title = "International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis",
abstract = "Introduction: An international cohort study of 73 anti-Ku-positive patients with different connective tissue diseases was conducted to differentiate the anti-Ku-positive populations of patients based on their autoantibody profile and clinical signs/symptoms and to establish possible correlations between antibodies against Ku p70 and Ku p80 with autoimmune diseases.Methods: Sera of anti-Ku-positive patients were collected from six European centers and were all secondarily tested (in the reference center); 73 were confirmed as positive. Anti-Ku antibodies were detected with counter-immunoelectrophoresis (CIE), line immunoassay (LIA), and immunoblot analyses. All clinical and laboratory data were follow-up cumulative data, except for anti-Ku antibodies. Statistical analyses were performed by using R (V 2.12.1). The Fisher Exact test was used to evaluate the association between anti-Ku antibodies and diagnosis, gender, clinical signs, and other observed antibodies. The P values were adjusted for multiple testing. Separation of disease populations based on the presence of antibodies and clinical signs was investigated by principal-components analysis, which was performed by using thr// R's prcomp function with standard parameters.Results: A 16{\%} higher prevalence of anti-Ku p70 was found over anti-Ku p80 antibodies. In 41 (57{\%}) patients, a combination of both was detected. Five (7{\%}) patients, who were CIE and/or LIA anti-Ku positive, were negative for both subsets, as detected with the immunoblot; 31{\%} of the patients had undifferentiated connective tissue disease (UCTD); 29{\%} had systemic sclerosis (SSc); 18{\%} had systemic lupus erythematosus (SLE); 11{\%} had rheumatoid arthritis; 7{\%} had polymyositis; and 3{\%} had Sj{\"o}gren syndrome.Conclusions: A significant positive association was found between female patients with anti-Ku p70 and joint/bone features, and a significant negative association was found between female patients with anti-Ku p80 only and joint/bone features (P = 0.05, respectively). By using the first and the third components of the principal-component analysis (PCA) with 29 parameters evaluated, we observed that the anti-Ku-positive population of UCTD patients had overlapping parameters, especially with SLE, as opposed to SSc, which could be helpful in delineating UCTD patients.",
author = "Katja Lakota and Thallinger, {Gerhard G.} and Snezna Sodin-Semrl and Blaz Rozman and Ales Ambrozic and Matija Tomsic and Sonja Praprotnik and Sasa Cucnik and Katjusa Mrak-Poljsak and Angela Ceribelli and Ilaria Cavazzana and Franco Franceschini and Jiri Vencovsky and L. Czirj{\'a}k and Cecilia Varj{\'u} and Gunther Steiner and Martin Aringer and Bojana Stamenkovic and Oliver Distler and Marco Matucci-Cerinic and Tanja Kveder",
year = "2012",
month = "1",
day = "6",
doi = "10.1186/ar3550",
language = "English",
volume = "14",
journal = "Arthritis Research and Therapy",
issn = "1478-6354",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - International cohort study of 73 anti-Ku-positive patients

T2 - Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis

AU - Lakota, Katja

AU - Thallinger, Gerhard G.

AU - Sodin-Semrl, Snezna

AU - Rozman, Blaz

AU - Ambrozic, Ales

AU - Tomsic, Matija

AU - Praprotnik, Sonja

AU - Cucnik, Sasa

AU - Mrak-Poljsak, Katjusa

AU - Ceribelli, Angela

AU - Cavazzana, Ilaria

AU - Franceschini, Franco

AU - Vencovsky, Jiri

AU - Czirják, L.

AU - Varjú, Cecilia

AU - Steiner, Gunther

AU - Aringer, Martin

AU - Stamenkovic, Bojana

AU - Distler, Oliver

AU - Matucci-Cerinic, Marco

AU - Kveder, Tanja

PY - 2012/1/6

Y1 - 2012/1/6

N2 - Introduction: An international cohort study of 73 anti-Ku-positive patients with different connective tissue diseases was conducted to differentiate the anti-Ku-positive populations of patients based on their autoantibody profile and clinical signs/symptoms and to establish possible correlations between antibodies against Ku p70 and Ku p80 with autoimmune diseases.Methods: Sera of anti-Ku-positive patients were collected from six European centers and were all secondarily tested (in the reference center); 73 were confirmed as positive. Anti-Ku antibodies were detected with counter-immunoelectrophoresis (CIE), line immunoassay (LIA), and immunoblot analyses. All clinical and laboratory data were follow-up cumulative data, except for anti-Ku antibodies. Statistical analyses were performed by using R (V 2.12.1). The Fisher Exact test was used to evaluate the association between anti-Ku antibodies and diagnosis, gender, clinical signs, and other observed antibodies. The P values were adjusted for multiple testing. Separation of disease populations based on the presence of antibodies and clinical signs was investigated by principal-components analysis, which was performed by using thr// R's prcomp function with standard parameters.Results: A 16% higher prevalence of anti-Ku p70 was found over anti-Ku p80 antibodies. In 41 (57%) patients, a combination of both was detected. Five (7%) patients, who were CIE and/or LIA anti-Ku positive, were negative for both subsets, as detected with the immunoblot; 31% of the patients had undifferentiated connective tissue disease (UCTD); 29% had systemic sclerosis (SSc); 18% had systemic lupus erythematosus (SLE); 11% had rheumatoid arthritis; 7% had polymyositis; and 3% had Sjögren syndrome.Conclusions: A significant positive association was found between female patients with anti-Ku p70 and joint/bone features, and a significant negative association was found between female patients with anti-Ku p80 only and joint/bone features (P = 0.05, respectively). By using the first and the third components of the principal-component analysis (PCA) with 29 parameters evaluated, we observed that the anti-Ku-positive population of UCTD patients had overlapping parameters, especially with SLE, as opposed to SSc, which could be helpful in delineating UCTD patients.

AB - Introduction: An international cohort study of 73 anti-Ku-positive patients with different connective tissue diseases was conducted to differentiate the anti-Ku-positive populations of patients based on their autoantibody profile and clinical signs/symptoms and to establish possible correlations between antibodies against Ku p70 and Ku p80 with autoimmune diseases.Methods: Sera of anti-Ku-positive patients were collected from six European centers and were all secondarily tested (in the reference center); 73 were confirmed as positive. Anti-Ku antibodies were detected with counter-immunoelectrophoresis (CIE), line immunoassay (LIA), and immunoblot analyses. All clinical and laboratory data were follow-up cumulative data, except for anti-Ku antibodies. Statistical analyses were performed by using R (V 2.12.1). The Fisher Exact test was used to evaluate the association between anti-Ku antibodies and diagnosis, gender, clinical signs, and other observed antibodies. The P values were adjusted for multiple testing. Separation of disease populations based on the presence of antibodies and clinical signs was investigated by principal-components analysis, which was performed by using thr// R's prcomp function with standard parameters.Results: A 16% higher prevalence of anti-Ku p70 was found over anti-Ku p80 antibodies. In 41 (57%) patients, a combination of both was detected. Five (7%) patients, who were CIE and/or LIA anti-Ku positive, were negative for both subsets, as detected with the immunoblot; 31% of the patients had undifferentiated connective tissue disease (UCTD); 29% had systemic sclerosis (SSc); 18% had systemic lupus erythematosus (SLE); 11% had rheumatoid arthritis; 7% had polymyositis; and 3% had Sjögren syndrome.Conclusions: A significant positive association was found between female patients with anti-Ku p70 and joint/bone features, and a significant negative association was found between female patients with anti-Ku p80 only and joint/bone features (P = 0.05, respectively). By using the first and the third components of the principal-component analysis (PCA) with 29 parameters evaluated, we observed that the anti-Ku-positive population of UCTD patients had overlapping parameters, especially with SLE, as opposed to SSc, which could be helpful in delineating UCTD patients.

UR - http://www.scopus.com/inward/record.url?scp=84855451722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855451722&partnerID=8YFLogxK

U2 - 10.1186/ar3550

DO - 10.1186/ar3550

M3 - Article

C2 - 22226402

AN - SCOPUS:84855451722

VL - 14

JO - Arthritis Research and Therapy

JF - Arthritis Research and Therapy

SN - 1478-6354

IS - 1

M1 - R2

ER -